7th European Post-chicago Melanoma/skin Cancer

Transcript

Congress Presidents Axel Hauschild, Kiel, Germany Claus Garbe, Tuebingen, Germany Final Program (updated: 13/4/2017) 7 th European Post-Chicago Melanoma/Skin Cancer Meeting Results and Interpretations of ASCO Presentations 2017: Interdisciplinary Global Conference on News in Melanoma/Skin Cancer June 29th  – 30th, 2017 Munich, Germany Leonardo Royal Hotel www.melanomaglobal2017.org Under the auspices of the European Association of Dermato-Oncology CONTENT   WELCOME MESSAGE 01   PROGRAM AT A GLANCE 02   PROGRAM 04 Thursday, June 29th 04 Friday, June 30th 07   CONGRESS FACULTY 10   FLOOR PLAN 13   SATELLITE SYMPOSIA OVERVIEW 14   GENERAL INFORMATION 16   SPONSORS 20   REGISTRATION FORM 23 WELCOME MESSAGE Dear colleagues and friends, The first Post-Chicago Meeting on Melanoma / Skin Cancer took place 2011. In 2016, the meeting has attracted more than 600 participants from almost 35 countries. The interactive congress offers a comprehensive overview on all new developments in melanoma diagnostics and therapy and a direct communication with the world´s leading experts in these fields. The aim of the Interdisciplinary Global Conference on News in Melanoma/ Skin Cancer in Munich is to grant a deep overall insight into the development of new drugs for melanoma and other cutaneous malignancies. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant. International key opinion leaders on melanoma will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany. Please join us for this event and submit your own studies and case presentations as free communications and as posters. We look forward to welcoming you in Munich in June 2017! Axel Hauschild, MD Congress President Claus Garbe, MD Congress President 1 PROGRAM AT A GLANCE THURSDAY, JUNE 29TH ROYAL BALLROOM R1+R2 8:00 9:00 Opening of the conference SYMPOSIUM I My personal highlights at ASCO 2017 10:00 11:00 KEY NOTE LECTURE COFFEE BREAK 12:00 SATELLITE SYMPOSIUM I with lunch (platinum sponsor) 13:00 SYMPOSIUM II Adjuvant treatment of melanoma PARALLEL SESSION I Intralesional treatments: current developments 14:00 COFFEE BREAK 15:00 SATELLITE SYMPOSIUM II (platinum sponsor) 16:00 SYMPOSIUM III Burning questions in treatment of skin cancer I 17:00 18:00 SYMPOSIUM IV Autoimmune adverse events: cases and management SYMPOSIUM 2 SATELLITE SYMPOSIUM KEY NOTE LECTURE PARALLEL SESSION FREE COMMUNICATIONS FRIDAY, JUNE 30TH ROYAL BALLROOM R1+R2 8:00 POSTER VIEWING & POSTER AWARD 9:00 10:00 11:00 12:00 13:00 KEY NOTE LECTURE SATELLITE SYMPOSIUM III (gold sponsor) COFFEE BREAK SATELLITE SYMPOSIUM IV with lunch (platinum sponsor) SYMPOSIUM V Recent advances in non-melanoma skin cancer PARALLEL SESSION II EADO Forum: Our most interesting melanoma cases 14:00 COFFEE BREAK 15:00 16:00 SATELLITE SYMPOSIUM VI (gold sponsor) SYMPOSIUM VI Unmet medical needs in melanoma therapy FREE COMMUNICATIONS 17:00 CLOSING REMARKS 18:00 3 THURSDAY, JUNE 29TH 09:30 OPENING OF THE CONFERENCE ROYAL BALLROOM CHAIRPERSON: CLAUS GARBE, TUEBINGEN, GERMANY EADO presidential address 09:40 –11:00 SYMPOSIUM I ROYAL BALLROOM My personal highlights at ASCO 2017 CHAIRPERSONS: ADIL DAUD, SAN FRANCISCO, USA CAROLA BERKING, MUNICH, GERMANY 09:40–10:00 10:05–10:25 10:30–10:50 … in immunotherapy Adil Daud, San Francisco, USA … in targeted therapies Dirk Schadendorf, Essen, Germany … in combined/sequential schedules Georgina Long, Sydney, Australia 11:00 –11:30 KEY NOTE LECTURE ROYAL BALLROOM CHAIRPERSON: R  OLAND KAUFMANN, FRANKFURT, GERMANY 11:00-11:30 The future role of radiotherapy in melanoma Jean Jacques Grob, Marseille, France 11:30 –12:00 COFFEE BREAK 12:00 –13:30 SATELLITE SYMPOSIUM I with lunch ROYAL BALLROOM (platinum sponsor) (see page 14) 4 THURSDAY, JUNE 29TH 13:30 –14:30 SYMPOSIUM II Adjuvant treatment of melanoma ROYAL BALLROOM CHAIRPERSONS: JEAN JACQUES GROB, MARSEILLE, FRANCE HUBERT PEHAMBERGER, VIENNA, AUSTRIA 13:30 –13:45 Ipilimumab – balance between efficacy and tolerability? Jean Jacques Grob, Marseille, France 13:50  –14:05 PD-1 antibodies Paul Lorigan, Manchester, United Kingdom 14:10 –14:25 Targeted therapies – risk for induction of resistance? Paolo Ascierto, Naples, Italy 13:30–14:30 PARALLEL SESSION I R1+R2 Intralesional treatments: current developments CHAIRPERSONS: MERRICK ROSS, HOUSTON, USA OLIVIER MICHIELIN, LAUSANNE, SWITZERLAND 13:30–13:42 T-VEC alone or in combination? Olivier Michielin, Lausanne, Switzerland 13:45–13:57 L19-IL2 (Darumab) alone or in combination? Benjamin Weide, Tuebingen, Germany 14:00–14:12 IL-12 electroporation Adil Daud, San Francisco, USA 14:15–14:27 PV-10 Merrick Ross, Houston, USA 14:30 –15:00 COFFEE BREAK 15:00 –16:30 SATELLITE SYMPOSIUM II ROYAL BALLROOM (platinum sponsor) (see page 14) 5 THURSDAY, JUNE 29TH 16:30 –17:50 SYMPOSIUM III Burning questions in treatment of skin cancer ROYAL BALLROOM CHAIRPERSONS: KATHARINA KÄHLER, KIEL, GERMANY OLIVIER MICHIELIN, LAUSANNE, SWITZERLAND 16:30–16:42 16:46–16:58 17:02–17:14 17:18–17:30 17:34–17:46 Checkpoint blockade: for 3 months or as long as possible? Adil Daud, San Francisco, USA Complete response: stop or continue treatment? Peter Mohr, Buxtehude, Germany Second-line therapy: resistance driven treatment decisions? Olivier Michielin, Lausanne, Switzerland Liver metastasis: surgery, perfusion or chemosaturation? Merrick Ross, Houston, USA Access to new drugs in Europe Lidija Kandolf-Sekulovic, Belgrade, Serbia 18:00 –19:00 SYMPOSIUM IV Autoimmune adverse events: cases and management ROYAL BALLROOM CHAIRPERSONS: LUCIE HEINZERLING, ERLANGEN, GERMANY CAROLINE ROBERT, PARIS, FRANCE 18:00–18:10 Hypophysitis Carola Berking, Munich, Germany 18:12–18:22 Colitis Ralf Gutzmer, Hanover, Germany 18:24–18:34 Neurological adverse events Caroline Robert, Paris, France 18:36–18:46 Hepatitis and pancreatis Celeste Lebbé, Paris, France 18:48–18:58 Cutaneous adverse events Carmen Loquai, Mainz, Germany 6 FRIDAY, JUNE 30TH 08:00 –09:00 POSTER VIEWING & POSTER AWARD ROYAL BALLROOM POSTER GUIDES: RALF GUTZMER, HANOVER, GERMANY KATHARINA KÄHLER, KIEL, GERMANY 09:00 –10:00 KEY NOTE LECTURE ROYAL BALLROOM CHAIRPERSON: GEROLD SCHULER, ERLANGEN, GERMANY 09:00– 09:30 Primary and secondary prevention of skin cancer Alexander Stratigos, Athens, Greece 09:30– 10:00 Is surgery replaced by systemic treatment in stage IV melanomas? Merrick Ross, Houston, USA 10:00–11:00 SATELLITE SYMPOSIUM III ROYAL BALLROOM (gold sponsor) (see page 15) 11:00 –11:30 COFFEE BREAK 11:30 –13:00 SATELLITE SYMPOSIUM IV with lunch ROYAL BALLROOM (platinum sponsor) (see page 15) 7 FRIDAY, JUNE 30TH 13:00 –14:20 SYMPOSIUM V Recent advances in non-melanoma skin cancer ROYAL BALLROOM CHAIRPERSONS: CELESTE LEBBÉ, PARIS, FRANCE CHRISTOPH HÖLLER, VIENNA, AUSTRIA 13:00–13:15  Merkel cell carcinoma: sensitive to immune checkpoint inhibition Celeste Lebbé, Paris, France 13:20–13:35 Advanced cutaneous squamous cell carcinoma: TKIs and immunotherapy Alexander Stratigos, Athens, Greece 13:40–13:55 Basal cell carcinoma: hedgehog inhibitors and more?! Reinhard Dummer, Zurich, Switzerland 14:00–14:15 Basal cell carcinoma syndrome and Xeroderma pigmentosum: what’s new? Christoph Höller, Vienna, Austria 13:00–14:20 PARALLEL SESSION II EADO Forum: Our most interesting melanoma cases R1+R2 CHAIRPERSONS: MATILDA BYLAITE˙ BUCˇINSKIENE˙, VILNIUS, LITHUANIA PETR ARENBERGER, PRAGUE, CZECH REPUBLIC 13:00–13:07 Case 1 Michael Fluck, Muenster, Germany 13:10–13:17 Case 2 Matilda Bylaite˙ Bucˇinskiene˙, Vilnius, Lithuania 13:20–13:27 Case 3 Zeljko Mijuskovic, Belgrade, Serbia 13:30–13:37 Case 4 Ketty Peris, Rome, Italy 13:40–13:47 Case 5 Lidija Kandolf-Sekulovic, Belgrade, Serbia 13:50–13:57 Case 6 Judit Oláh, Szeged, Hungary 14:00–14:07 Case 7 Iris Zalaudek, Graz, Austria 14:10–14:17 Case 8 Petr Arenberger, Prague, Czech Republic 8 FRIDAY, JUNE 30TH 14:20 –15:00 COFFEE BREAK 15:00 –16:00 SATELLITE SYMPOSIUM VI ROYAL BALLROOM (gold sponsor) (see page 15) 16:00 –17:25 SYMPOSIUM VI Unmet medical needs in melanoma therapy ROYAL BALLROOM CHAIRPERSONS: CELESTE LEBBÉ, PARIS, FRANCE FRIEDEGUND MEIER, DRESDEN, GERMANY 16:00 –16:18 Mucosal melanomas: targeted or immunotherapies? Jennifer Landsberg, Essen, Germany 16:21 –16:39 Metastatic ocular melanoma: an untreatable disease? Bastian Schilling, Wuerzburg, Germany 16:42 –17:00 Brain metastasis: still a dilemma! Friedegund Meier, Dresden, Germany 17:03 –17:21 Treatment for immunosuppressed patients Celeste Lebbé, Paris, France 16:00 –17:25 FREE COMMUNICATIONS R1+R2 CHAIRPERSONS: KETTY PERIS, ROME, ITALY PETR ARENBERGER, PRAGUE, CZECH REPUBLIC 17:25 –17:30 CLOSING REMARKS Axel Hauschild, Kiel, Germany 9 CONGRESS FACULTY A Petr Arenberger, MD Department of Dermatology Charles University 3rd School of Medicine Srobarova 50 CZ-100 34 Prague Czech Republic Phone: +420-26716-3000 Email: [email protected] Paolo A. Ascierto, MD Melanoma, Cancer Immunotherapy and Innovative Therapy Unit Istituto Nazionale Tumori Fondazione “G. Pascale” Via Mariano Semmola 80131 Naples Italy Phone: +39-081-5903236 Email: [email protected] B Carola Berking, MD Professor of Dermatology Department of Dermatology and Allergology University Hospital Munich (LMU) Frauenlobstr. 9–11 80337 Munich Germany Phone: +49-89-4400-56225 Email: [email protected] Matilda Bylaite˙ Bucˇ inskiene˙, MD Professor of Dermatology Chairwoman of the Centre of Dermatovenereology President of Lithuanian Association of Dermatovenereologists Vilnius University Hospital Santariskiu Klinikos Kairiukscio str. 2 08411 Vilnius Lituania Phone: +370-5-2720385 Email: [email protected] D Adil I. Daud, MD Clinical Professor of Medicine and Co-Director of the Melanoma Program UCSF Melanoma Center 1600 Divisadero St., Fourth Floor San Francisco, CA 94115 USA Phone: +1-415-353-7382 Email: [email protected] 10 Reinhard Dummer, MD Professor of Dermatology Department of Dermatology Vice Chairman, University of Zurich Hospital Gloriastrasse 31 8091 Zurich Switzerland Phone: +41-442552507 Email: [email protected] Ralf Gutzmer, MD Professor of Dermatology Skin Cancer Center, Department of Dermatology Hannover Medical School Carl-Neuberg-Str. 1 30625 Hannover Germany Phone: +49-511-532-0 Email: [email protected] E H Alexander M. M. Eggermont, MD Professor of Surgery Directeur Général, Institut de Cancérologie Gustave Roussy 114 Rue Edouard Vaillant 94800 Villejuif/Paris France Phone: +33-142-114016 E-Mail: [email protected] Sebastian Haferkamp, MD Department of Dermatology University Hospital Regensburg Franz-Josef-Strauß-Allee 11 93053 Regensburg Germany Phone: +49-941-944-9605 Email: [email protected] F Michael Fluck, MD Fachklinik Hornheide Dorbaumstraße 300 48157 Muenster Germany Phone: +49-251-3287431 Email: [email protected] G Claus Garbe, MD Professor of Dermatology Department of Dermatology Eberhard Karls University Liebermeister Str. 25 72076 Tuebingen Germany Phone: +49-7071-2987110 Email: [email protected] Jean Jacques Grob, MD Professor of Dermatology Service de Dermatology and Cancer Research Hospital de la Timone 264 Rue St. Pierre 13005 Marseille France Phone: +33-491-388591 Email: [email protected] Axel Hauschild, MD Professor of Dermatology Department of Dermatology University of Kiel Rosalind-Franklin-Str. 7 24105 Kiel Germany Phone: +49-431-50021131 Email: [email protected] Lucie Heinzerling, MD, PhD, MPH Professor Department of Dermatology University Hospital of Erlangen Ulmenweg 18 91054 Erlangen Germany Phone: +49-9131-8539037 Email: [email protected] Christoph Höller, MD Professor of Dermatology Department of Dermatology Medical University of Vienna Waehringer Guertel 18–20 1090 Vienna Austria Phone: +43-1-404004786 Email: [email protected] K Katharina Kähler, MD Department of Dermatology University of Kiel Rosalind-Franklin-Str. 7 24105 Kiel Germany Phone: +49-431-500-91192 Email: [email protected] Lidija Kandolf-Sekulovic, MD Department of Dermatology Military Medical Academy Crnotravska 17 11000 Belgrade Serbia Phone: +381-113608583 Email: [email protected] Roland Kaufmann, MD Professor of Dermatology, Director Department of Dermatology Clinical Center J. W. Goethe University Theodor-Stern-Kai 7 60590 Frankfurt am Main Germany Phone: +49-69-63015311 Email: [email protected] L Jennifer Landsberg, MD Professor of Immunodermatology University Hospital Essen Department of Dermatology Hufelandstr. 55 45122 Essen Germany Phone: +49-201-723-2326 Email: [email protected] Celeste Lebbé, MD Professor of Dermatology Department of Dermatology Hospital Saint-Louis Avenue Claude-Vellefaux 1 75010 Paris France Phone: +33-142494679 Email: [email protected] Georgina Long, MD, PhD Associate Professor of Melanoma Biology and Translational Research Melanoma Institute Australia The University of Sydney 40 Rocklands Road North Sydney NSW 2060 Australia Phone: +61-2-9911-7336 Email: [email protected] Carmen Loquai, MD Department of Dermatology Johannes Gutenberg University Langenbeckstr. 1 55131 Mainz Germany Phone: +49-6131-17-6032 Email: [email protected] Paul Lorigan, MD, FRCP Professor of Medical Oncology Division of Molecular and Clinical Cancer Sciences Faculty of Biology, Medicine and Health University of Manchester; Christie NHS Foundation Trust Wilmslow Road, Withington Manchester M20 4BX United Kingdom Phone: +44-1614468002 Email: [email protected] M Daniela Massi, MD Associate Professor of Pathology Division of Pathological Anatomy Department of Surgery and Translational Medicine University of Florence Director, Histopathology and Molecular Diagnostics Careggi University Hospital Largo Brambilla, 3 50134 Florence Italy Phone: +39-055-4478137 Email: [email protected] Friedegund Meier, MD Professor of Dermatooncology Department of Dermatology University Hospital Carl Gustav Carus Technical University Dresden Fetscherstr. 74 01307 Dresden Germany Phone: +49-351-4583677 Email: [email protected] Olivier Michielin, MD Head of Melanoma Clinic Department of Oncology Swiss Institute of Bioinformatics Ludwig Institute 1015 Lausanne Switzerland Phone: +41-21-692-4053 Email:[email protected] Zeljko Mijuskovic, MD President of Serbian Association of Dermatovenereologists Clinic of Dermatovenereology Faculty of Medicine, Military Medical Academy 17 Crnotravska 11000 Belgrade Serbia Phone: +381-11-3609183 Email: [email protected] Peter Mohr, MD Center of Dermatology Elbe Klinikum Buxtehude Am Krankenhaus 1 21614 Buxtehude Germany Phone: +49-41617036209/-6250 Email: [email protected] O Judit Oláh, MD Department of Dermatology University of Szeged Koranyi Fasor 6 3720 Szeged Hungary Phone: +36-62-545984 Email: [email protected] P Hubert Pehamberger, MD Medical Director Rudolfinerhaus Pricate Clinic Billrothstraße 78 1190 Vienna Austria Phone: +43-1-36036-6010 Email: [email protected] Ketty Peris, MD Department of Dermatology Catholic University of Rome Largo a Gemelli, 8 00168 Rome Italy Phone: +39-630154227 Email: [email protected] R Caroline Robert MD, PhD Head Dermatology Gustave Roussy Institute 114 rue Edouard Vaillant 94801 Villejuif France Phone: +33-1-4211-64-97 Email: [email protected] Merrick I. Ross, MD The University of Texas Anderson Cancer Center 1515 Holcombe Blvd Houston, TX 77030 USA Phone: +1-877-632-6789 11 S Z Dirk Schadendorf, MD Professor of Dermatology Department of Dermatology University Hospital Essen Hufelanstr. 55 45147 Essen Germany Phone: +49-201-7232430 Email: [email protected] Iris Zalaudek, MD Division of Dermatology and Venerology Non-Melanoma Skin Cancer Unit Medical University of Graz Auenbruggerplatz 8 8036 Graz Austria Phone: +43-6763328269 Email: [email protected] Bastian Schilling, MD Department of Dermatology University Hospital Wuerzburg Josef-Schneider-Str. 2 97080 Wuerzburg Phone: +49-931-201-26779 Email: [email protected] Gerold Schuler, MD Professor of Dermatology Department of Dermatology University Hospital Erlangen Ulmenweg 18 91054 Erlangen Germany Phone: +49-9131-85-33661 Email: [email protected] Alexander Stratigos, MD Department of Dermatology University of Athens School of Medicine Andreas Sygros Hospital 5 Dragoumi Street Athens 161 21 Greece Phone: +30-210-7231731 Email: [email protected] W Benjamin Weide, MD Department of Dermatology Eberhard Karls University Liebermeister Str. 25 72076 Tuebingen Germany Phone: +49-7071-2984555 Email: benjamin.weide@ med.uni-tuebingen.de 12 ERDGESCHOSS/GROUND FLOOR UNTERGESCHOSS/BASEMENT LEONARDO ROYAL HOTEL MUNICH FLOOR PLAN 13 SATELLITE SYMPOSIA OVERVIEW THURSDAY, JUNE 29TH 2:00 –13:30 SATELLITE SYMPOSIUM I with lunch 1 Amgen (platinum sponsor) ROYAL BALLROOM Going viral with melanoma immunotherapy CHAIRPERSONS: C  AROLA BERKING, MUNICH, GERMANY DIRK SCHADENDORF, ESSEN, GERMANY 12:00–12:05 Welcome and introduction Carola Berking, Munich, Germany 12:05–12:20 Locoregional therapies in melanoma – what is new? Christoph Höller, Vienna, Austria 12:20–13:00 Practical considerations when using an oncolytic virus in the clinic: a case based discussion Sebastian Haferkamp, Regensburg, Germany Peter Mohr, Buxtehude, Germany 13:00–13:20 Combination strategies – the future use of oncolytic viruses in melanoma Axel Hauschild, Kiel, Germany 13:20–13:30 Q & A summary and closure Dirk Schadendorf, Essen, Germany 5:00 –16:30 SATELLITE SYMPOSIUM II 1 Bristol-Myers Squibb (platinum sponsor) ROYAL BALLROOM The I-O-Approach in Advanced Melanoma – From an Innovation to a Standard Therapy CHAIRPERSON: DIRK SCHADENDORF, ESSEN, GERMANY 15:00–15:25 Checkpoint modifiers in advanced melanoma – data from CheckMate 067 and beyond Dirk Schadendorf, Essen, Germany 15:30–15:55 Clinical factors, biomarkers, guidelines – and how they contribute to an individual therapy decision Georgina Long, Sydney, Australia 16:00–16:25 Focus on clinical practice – case studies Peter Mohr, Buxtehude, Germany 14 FRIDAY, JUNE 30TH 10:00 –11:00 SATELLITE SYMPOSIUM III Roche (gold sponsor) ROYAL BALLROOM 11:30 –13:00 SATELLITE SYMPOSIUM IV with lunch MSD (platinum sponsor) ROYAL BALLROOM The class of 2017 melanoma management: Art or Maths? 11:30–11:45 Welcome and introductions 11:45–12:05 ART: Evolution of melanoma management now focuses on the art of optimizing treatment selection 12:05–12:25 MATHS: Evolution of melanoma management is a numbers game with breakthroughs still to come 12:25–12:45 Facilitated counter arguments & summaries 12:45–13:00 Q & A Panel Discussion 15:00 –16:00 SATELLITE SYMPOSIUM VI Novartis (gold sponsor) ROYAL BALLROOM Real-World Treatment of BRAF-Mutant Melanoma: A Multidisciplinary Tumor Board CHAIRPERSON: DIRK SCHADENDORF, ESSEN, GERMANY 15:00–15:05 Welcome Dirk Schadendorf, Essen, Germany 15:05–15:55 Multi-disciplinary patient case discussion Alexander Eggermont, Villejuif, France Daniela Massi, Florence, Italy Dirk Schadendorf, Essen, Germany 15:55–16:00 Close Dirk Schadendorf, Essen, Germany 15 GENERAL INFORMATION Accommodation Individual hotel reservation: Please contact the congress hotel or one of the hotels nearby directly for your individual room bookings. Since there will be the trade fair “LASER World of PHOTONICS 2017” in Munich, June 26–29, 2017, we recommend to book your accommodation as soon as possible! MedConcept has reserved a limited number of rooms under the reference “European Post-Chicago Meeting 2017” in the following hotels: Leonardo Royal Hotel Munich**** Moosacher Str. 90, 80809 Munich Phone: +49 (0)89 62039779, Fax: +49 (0)89 62039717, E-Mail: [email protected] Rate per standard room and night: 179 Euro single and 202 Euro double, breakfast included Booking deadline: May 23rd, 2017 Park Inn by Radisson Munich Frankfurter Ring*** Frankfurter Ring 20-22, 80807 Munich Phone: +49 (0)89 35717 0, Fax: +49 (0)89 35717 700, E-Mail: [email protected] Rate per standard room and night: 139,00 Euro single and 169,00 Euro double, breakfast included Booking deadline: May 31st, 2017 Distance to Leonardo Royal Hotel: 2,5 km Hotel Königstein*** Frankfurter Ring 28-30, 80807 Munich Phone: +49 (0)89 35036 0, Fax: +49 (0)89 35036 100, E-Mail: [email protected] Rate per standard room and night: 154,00 Euro single or 184,00 Euro queen-size bed and 204,00 Euro double, breakfast included Booking deadline: May 31st, 2017 Distance to Leonardo Royal Hotel: 2,5 km All booking of rooms only according to availability! All rates include 19 % VAT! Call for Abstracts All those interested in presenting abstracts at the 7th European Post-Chicago Melanoma Meeting are invited to submit their work to the Program Committee for review. Selected abstracts will be chosen for an oral presentation during the Free Communications Sessions. The best oral presentation and poster on display will be awarded during the congress with an award of 500 Euro each. The acceptance of an abstract does not include the congress registration. Abstracts can be submitted online at www.melanomaglobal2017.org. Deadline Abstract Submission: May 1st, 2017 16 Congress Venue Leonardo Royal Hotel Munich, Moosacher Straße 90, 80809 Munich Phone: +49 (0)89 2885380, E-Mail: [email protected] www.leonardo-hotels.com/Leonardo_Royal_Hotel_Munich Congress Date June 29th–June 30th, 2017 CME Credits An application for CME accreditation will be made. How to receive your CME Credits To obtain CME credits please fill in the evaluation form, which you will find in your congress bag and in the meeting rooms. To get your certificate of attendance with the CME credits please return the evaluation form duly filled in to the registration desk. Cancellation Policy Cancellations must be received in writing by May 1st, 2017. No refunds will be granted after that date. To cancel a registration, please send an email to [email protected] and include “European Post-Chicago Melanoma Meeting 2017 Cancellation” in the subject line. A processing fee of 30 Euro will be deducted from each cancelled registration. Substitutions (new ticket holder must come from the same institution) are possible and must be received in writing by June 18th, 2017. To substitute a registration please send an email including the name of the original registrant and the name of the person substituting to [email protected] and include “European PostChicago Melanoma Meeting 2017 Substitution” in the subject line. The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the meeting be hindered or prevented by unexpected, political or economic events or generally by force, or should the non-appearance of speakers or other reasons need program changes. With registration, the participant accepts this proviso. Exhibition A commercial exhibition will be held at the congress venue, close to the main rooms. Exhibition Opening Hours Thursday, June 29th, 2017 09:00–19:00 Friday, June 30th, 2017 07:30–17:00 Insurance The Organizer does not accept liability for individual medical, travel or personal insurance and participants are strongly advised to make their own arrangements in respect to health and travel insurance. Language and Translation The official language of the meeting will be English. Simultaneous translation will not be provided. 17 Passport and Visa For most nationalities visas are not required for entering Germany. For further information about visa and passport please contact the German embassy in your country. If an invitation letter for visa purposes is required please contact MedConcept. Registration and Information Desk The registration desk is situated at the ground floor of the Leonardo Royal Hotel to the left of the reception. Registration Desk Opening Hours Wednesday, June 28th, 2017 17:00–19:00 (early check-in) Thursday, June 29th, 2017 08:00–19:30 Friday, June 30th, 2017 07:30–17:30 Registration Please visit the congress website www.melanomaglobal2017.org for online registration or fill out the registration form on the last page of the program. Registration Fees Early registration until April 3rd From April 4th until June 18th On site Full Delegates 300 Euro 400 Euro 500 Euro Doctors in training* and Eastern European Countries 200 Euro 250 Euro 300 Euro Day Ticket 150 Euro 200 Euro 250 Euro *Please forward appropriate documentary evidence via mail, email or fax to the congress office: MedConcept GmbH, Friedenstraße 58, 15366 Neuenhagen bei Berlin, Germany, [email protected], Fax: +49 (0)3342 42689-30 After June 18th, 2017 all registrations have to be made on-site at the meeting venue. Important Dates Early Registration Fee: till April 3 rd, 2017 Deadline Abstract Submission: May 1st, 2017 Notification of Acceptance of Abstracts: May 15 th, 2017 Closing of Pre-Registration: June 18 th, 2017 Congress Organization Gesellschaft für medizinische Projekte mbH Friedenstraße 58 · 15366 Neuenhagen bei Berlin, Germany [email protected] · www.medconcept.org Phone +49 (0)3342 42689-30 · Fax +49 (0)3342 42689-40 www.melanomaglobal2017.org For patients with regionally or distantly metastatic melanoma, stage IIIB, IIIC and IVM1a* IMLYGIC® (talimogene laherparepvec) APPROVED IN THE EU INJECT THE LESION. IGNITE AN IMMUNE RESPONSE. THAT’S THE PRECISION OF IMLYGIC®. *Indication IMLYGIC® is indicated for the treatment of adults with unresectable melanoma that is regionally or distantly metastatic (Stage IIIB, IIIC and IVM1a) with no bone, brain, lung or other visceral disease (see sections 4.4 and 5.1 of the Summary of Product Characteristics).1 Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Jeder Verdachtsfall einer Nebenwirkung sollte gemeldet werden. Kurzinformation: IMLYGIC® 106 Plaque-bildende Einheiten (PFU)/ml Injektionslösung IMLYGIC® 108 Plaque-bildende Einheiten (PFU)/ml Injektionslösung Wirkstoff: Talimogen laherparepvec Zusammensetzung: Arzneilich wirksamer Bestandteil: Jede Durchstechflasche enthält 1 ml entnehmbares Volumen Imlygic in einer nominalen Konzentration von 1 x 106 (1 Million)/1 x 108 (100 Millionen) Plaque-bildenden Einheiten (PFU)/ml. Sonstige Bestandteile: Dinatriumphosphat-Dihydrat, Natriumdihydrogenphosphat-Dihydrat, Natriumchlorid, Myo-Inositol, Sorbitol (E 420), Wasser für Injektionszwecke. Jede Dosis von 4 ml enthält ungefähr 30 mg (1,3 mmol) Natrium und 80 mg Sorbitol. Talimogen laherparepvec wird mittels rekombinanter DNA-Technologie in Vero-Zellen hergestellt. Anwendungsgebiet: Imlygic ist indiziert zur Behandlung von Erwachsenen mit nicht resezierbarem, lokal oder entfernt metastasiertem Melanom (Stadium IIIB, IIIC und IVM1a) ohne Knochen-, Hirn-, Lungen- oder andere viszerale Beteiligung. Gegenanzeigen: Patienten mit einer Vorgeschichte einer Überempfindlichkeit gegen Talimogen laherparepvec oder einen der sonstigen Bestandteile. Patienten, die schwer immungeschwächt sind (z. B. Patienten mit schwerer angeborener oder erworbener zellulärer und/oder humoraler Immunschwäche). Nebenwirkungen: Sehr häufig: peripheres Ödem, Kopfschmerzen, Husten, Erbrechen, Diarrhö, Obstipation, Übelkeit, Myalgie, Arthralgie, Schmerzen in den Extremitäten, grippeähnliche Erkrankung, Pyrexie, Schüttelfrost, Fatigue, Schmerzen, Reaktionen an der Injektionsstelle. Häufig: Zellulitis, oraler Herpes, Tumorschmerzen, infizierte Neoplasien, Anämie, immunvermittelte Ereignisse, Dehydratation, Verwirrtheit, Angst, Depression, Schwindel, Schlaflosigkeit, Ohrenschmerzen, Tachykardie, tiefe Venenthrombose, Hypertonie, Erröten, Belastungsdyspnoe, oropharyngeale Schmerzen, Infektion der oberen Atemwege, abdominale Schmerzen, abdominales Unwohlsein, Vitiligo, Hautausschlag, Dermatitis, Rückenschmerzen, Schmerzen in der Leiste, Unwohlsein, Schmerzen in der Achselhöhle, Gewichtsverlust, Wundkomplikationen, Wundsekretion, Quetschung, Schmerzen durch den Eingriff. Gelegentlich: Infektion der Inzisionsstelle, Plasmozytom an der Injektionsstelle, herpetische Keratitis, obstruktive Atemwegserkrankung. Weitere Angaben: s. Fach- und Gebrauchsinformation Verschreibungspflichtig Stand der Information: Juli 2016 AMGEN Europe B.V., 4817 ZK Breda, Niederlande (örtlicher Vertreter Deutschland: AMGEN GmbH, 80992 München) For further information please consult the Summary of Product Characteristics (SmPC). Reference: 1. Imlygic Summary of Product Characteristics. © 2017 Amgen Inc. All rights reserved. EUHQ-P-678x-0116-122547(1)a. February 2017 SPONSORS PLATINUM 120,000 Euro Platinum Sponsorship 120,750 Euro Platinum Sponsorship incl. Meeting Room GOLD 90,000 Euro Gold Sponsorship BRONZE FURTHER SPONSORS Delcath Systems Limited medac GmbH 20 NOTES 21 22 REGISTRATION FORM June 29th–30th, 2017 · 7 th European Post-Chicago Melanoma / Skin Cancer Meeting 2017 Results and Interpretations of ASCO Presentations 2017: Interdisciplinary Global Conference on News in Melanoma/Skin Cancer First Name:    Last Name:  Professional Title:  Gender:   Male   Degree:   MD   PhD   RN   PA-C  Other   Female  Speciality:  Institution:   Address:  City:   State:  Daytime Telephone:    Zip Code:    Fax:   Country:   E-Mail:  Fees (VAT included) Early registration till April 3rd From April 4th till June 18th On site Full Delegates   300 Euro   400 Euro   500 Euro Doctors in training* and Eastern European Countries   200 Euro   250 Euro   300 Euro Day Ticket    150 Euro   200 Euro   250 Euro   June 29th    June 30th *Please forward appropriate documentary evidence via mail, email or fax to the congress office: MedConcept GmbH, Friedenstraße 58, 15366 Neuenhagen bei Berlin, Germany, [email protected], Fax: +49 (0)3342 42689-40 An invoice will be send by email to the address provided. Total Amount:   Euro Payment Method Bank Transfer (Euro):  Credit Card:   MasterCard   Credit Card Number:  Expiration Date:  Security Code CCV:  Cardholder Name:  Visa     American Express   (MC/Visa – 3 digits on back, AMEX – 4 digits on front) Signature:   By completing the registration form, the participant accepts the general terms and conditions as well as the cancellation policy given on the congress website at www.melanomaglobal2017.org and agrees that his/her data may be used, processed and published (e.g. within the list of participants) for organizational purposes of the event. The participant accepts that MedConcept will contact him/her by email for organizational matters (e.g. the registration confirmation and invoice) and information related to the event.  I accept until further notice that MedConcept will inform me about future events by email. Congress Organization Gesellschaft für medizinische Projekte mbH · Friedenstraße 58 · 15366 Neuenhagen bei Berlin Phone +49 (0)3342 42689-30 · Fax +49 (0)3342 42689-40 · [email protected] · www.medconcept.org